deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT00130312

Effect of Sulodexide in Overt Diabetic Nephropathy

The Collaborative Study Group Trial: The Effect of Sulodexide in Overt Type 2 Diabetic Nephropathy

Sponsor: Collaborative Study Group (CSG)

Conditions Diabetic Nephropathy
Interventions Placebo Sulodexide
Updated 8 times since 2017 Last updated: Mar 17, 2021 Started: Aug 31, 2005 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No difference in protein excretion at 6\&12 months. No safety issues.

Other terminated trials from Collaborative Study Group (CSG)

More terminations from Collaborative Study Group (CSG)

A PHASE4 clinical study on Diabetic Nephropathy, this trial is terminated or withdrawn. The trial is conducted by Collaborative Study Group (CSG) and has accumulated 8 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotTerminated~Apr 2021 – ~Apr 2022 · 12 months · monthly snapshotTerminated~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Apr 2022 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Apr 2021 — Apr 2022 [monthly]

    Terminated PHASE4

  5. Jan 2021 — Apr 2021 [monthly]

    Terminated PHASE4

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Collaborative Study Group (CSG)
  • Keryx Biopharmaceuticals
Data source: Keryx Biopharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations